Consideration on the design of early phase clinical trial of new anticancer drugs
Lyu, Q.; Xu, J.
Zhonghua Zhong Liu Za Zhi 37(3): 235-240
2015
ISSN/ISBN: 0253-3766 PMID: 25975797 Document Number: 680432
Document emailed within 1 workday
Related Documents
Sugiyama, Y.; Kobayashi, T.; Inaba, M. 1987: Quantitative analysis of cell-kill effects of anticancer drugs: consideration of both in vitro and in vivo experimental systems Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(12): 3183-3198White, R.; Chileshe, M.; Dawson, L.; Donnell, D.; Hillier, S.; Morar, N.; Noguchi, L.; Dixon, D. 2011: Fostering community understanding of sufficient benefit and early stopping for a phase 2B HIV prevention clinical trial in Africa Clinical Trials 8(1): 103-111
Galler, A.S.; Bauer, T.L. 2009: A randomised phase II trial of preoperative chemotherapy of cisplatindocetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) Yearbook of Oncology 2009: 194-195
Ogawa, M. 1983: Current clinical status of new anticancer drugs Gan no Rinsho. Japan Journal of Cancer Clinics 29(10): 1049-1052
Collins, J.M. 1988: Improving the use of anticancer drugs: clinical pharmacokinetic approaches Israel Journal of Medical Sciences 24(9-10): 483-487
Jaillon, P.; Dupuis, B. 1989: Prerequisites for phase i and phase Ii clinical trials of drugs Archives des Maladies du Coeur et des Vaisseaux 82(10): 1773-1776
Sugihara, K.; Auther, C.; Mori, S.; Nishihira, T.; Matsumoto, T.; Kawachi, S.; Ishikawa, M.; Takahashi, M.; Nakajima, T.; Kosaki, G. 1990: Early phase Ii study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90 Study group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2405-2413
Teehan, M. 1994: Guidelines for phase IV clinical trials. Joint Committee on Phase IV Clinical Trial Guidelines Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 39(10): 629-633
Yang, S.C. 1990: Correlation of in vitro chemosensitivity and clinical responses to anticancer drugs in primary adenocarcinoma of the lung Journal of the Formosan Medical Association 89(3): 214-219
Ogawa, M.; Masaoka, T.; Yamada, K.; Kimura, K. 1993: Early phase Ii study of Idarubicin, a new anthracycline anticancer drug, in acute leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(7): 897-906
Kitada, M.; Sawaragi, I. 1996: Clinical evaluation of granisetron hydrochloride against nausea and vomiting induced by anticancer drugs for gynecological malignant tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(1): 87-91
Katayose, Y.; Yamamoto, K.; Nakagawal, K.; Takemura, S.; Takahashi, M.; Nakamura, R.; Shimamura, H.; Rikiyama, T.; Egawa, S.; Yoshda, H.; Motoi, F.; Naitoh, T.; Unno, M. 2015: Feasibility Assessment of Modified FOLFOX-6 as adjuvant treatment after resection of liver metastases from colorectal cancer: analyses of a multicenter phase II clinical trial (Miyagi-HBPCOG Trial-001) Hepato-Gastroenterology 62(138): 303-308
Wohlzogen, F.X. 1970: Design and analysis of a clinical trial of antihypertensives Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(1): 157-160
Yoshimura, A.; Yamano, Y.; Gemma, A.; Yoshimori, K.; Hayashihara, K.; Taniguchi, Y.; Uematsu, K.; Shibuya, M.; Kudoh, S.; Niitani, H. 1993: An early phase Ii trial combining cisplatin and carboplatin in advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(4): 503-508
Hao, L.; Zhao, X.-F.; Li, J. 2009: Approach to clinical trial design for acupuncture and moxibustion treatment of stroke Zhongguo Zhen Jiu 29(1): 56-58
Marr, K.A. 2004: Antifungal therapy for febrile neutropenia: issues in clinical trial design Current Opinion in Investigational Drugs 5(2): 202-207
Furue, H.; Kako, M.; Mugitani, H.; Fuse, K.; Hirota, F.; Sakamoto, K.; Takahashi, T.; Ezaki, M.; Yamada, K.; Suminaga, M.; Kaise, R. 1983: Phase Ii clinical trial of MCNU Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(7): 1679-1683
Marshall, L.L.; Frye, R.F.; Murphy, J.E. 1990: Students' experience in a phase IIi clinical trial American Journal of Hospital Pharmacy 47(5): 1014; 1016
Breneman, D.; Sheth, P.; Berger, V.; Naini, V.; Stevens, V. 2007: Phase Ii clinical trial of bexarotene gel 1% in psoriasis Journal of Drugs in Dermatology: Jdd 6(5): 501-506
Stamm, D. 1971: Quality control of clinical-chemical examinations in clinical trial of drugs Arzneimittel-Forschung 21(10): 1517-1519